Page 1 of 33 Diabetes Metabolite profiling of LADA challenges the view of a metabolically distinct subtype Mahmoud Al-Majdoub1,*, Arslan Ali1,2*, Petter Storm3, Anders Rosengren4, Leif Groop1,5, and Peter Spégel1,6 1 Unit of Molecular Metabolism, Department of Clinical Sciences in Malmö, Lund University, SE-20502 Malmö, Sweden. 2 H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan 3 Diabetes and Endocrinology, Department of Clinical Sciences in Malmö, Lund University, SE-20502 Malmö, Sweden. 4 Translational Diabetes Research, Department of Clinical Sciences in Malmö, Lund University, SE-20502 Malmö, Sweden. 5 Finnish Institute for Molecular Medicine (FIMM), Helsinki University, Helsinki, Finland. 6 Centre for Analysis and Synthesis, Department of Chemistry, Lund University, SE- 221 00 Lund, Sweden. * Equal contribution Keywords: Metabolism; latent autoimmune diabetes in adults; type 1 diabetes; type 2 diabetes; metabolomics. Word count: 2868 Number of Figures: 3 Number of tables: 3 Running title: The metabolite profile of diabetes Corresponding author: Peter Spégel, Department of Chemistry, Centre for Analysis and Synthesis, Naturvetarvägen 14, 223 62 Lund, Sweden. Email:
[email protected], Tel: +46-40-391009 1 Diabetes Publish Ahead of Print, published online December 2, 2016 Diabetes Page 2 of 33 ABSTRACT Latent autoimmune diabetes in adults (LADA) usually refers to GADAb positive diabetes with onset after 35 years of age and no insulin treatment within the first 6 months after diagnosis. However, it is not always easy to distinguish LADA from type 1 or type 2 diabetes. In this study we examined whether metabolite profiling could help to distinguish LADA (N=50) from type 1 (N=50) and type 2 diabetes (N=50).